Evidence map›Paper›PMID 1396747›Full record

ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology1992

Impact of the changing epidemiology of fungal infections in the 1990s.

M Pfaller, R Wenzel

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2006
    Pooled it
  2. Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1997
    Trial
  3. Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1994
    Trial
  4. Article
  5. Review
  6. Review
  7. [Invasive fungal disease: the old question and new confusion to Chinese physician].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2019
    Article
  8. Profile of yeasts isolated from urinary tracts of catheterized patients.Journal of clinical and diagnostic research : JCDR · 2014
    Article
  9. Epidemiology of infections in cancer patients.Cancer treatment and research · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. New chromogenic agar medium for the identification of Candida spp.Applied and environmental microbiology · 2002
    Article
  17. Article
  18. Antifungal proteins.Applied and environmental microbiology · 2001
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M PfallerDepartment of Pathology, Oregon Health Sciences University, Portland 97201-3098.
R Wenzel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increase in fungal infections over the past decade is striking. This is particularly true for hospitalized patients where the rate of candidal bloodstream infection has increased by as much as 487% over the decade of the 1980s. This increase in fungal infections is accompanied by a significant excess mortality and excess length of stay in hospital. The emergence of "new" fungal pathogens such as Candida krusei, Torulopsis glabrata, Fusarium and Trichosporon beigelii is now recognized as a significant problem in many patient populations. The documentation of nosocomial transmission of fungal pathogens and the recognition of resistance to both new and established anti-fungal agents poses a significant problem entering the 1990s. Continued effort is needed to develop new and better therapeutic agents and more effective strategies for prophylaxis of endogenous infections and prevention of transmission within the hospital setting.

Indexed as

CandidiasisCross InfectionDrug Resistance, MicrobialFungemiaHumansMycosesOpportunistic InfectionsRisk Factors

Identifiers

PMID1396747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.